Do you have event related questions or need help with registration?
8:00am | Registration |
9:00am | Continuous Glucose Meters Sarah Steedman, PharmD |
10:00am | Depression Update Haley Simkins, PharmD |
11:00am | Break |
11:15am | Asthma Update Anna Hale, PharmD |
12:15pm | Lunch |
1:00pm | Weight Loss Medications Allison Fay, PharmD |
2:00pm | Epilepsy Update Victor Dostrow, MD, FAES |
3:00pm | Adjourn |
|
Compare features of current continuous glucose monitoring (CGM) devices in order to select the most appropriate device based on patient characteristics. (P/PT) |
|
Interpret key glucose data using an ambulatory glucose profile (AGP) in order to guide patient treatment decisions. (P) |
|
Identify appropriate first line therapy options for MDD. (P/PT) |
|
Understand pertinent drug interactions related to these agents and how to navigate them. (P) |
|
State the recommendations for stepwise approach to asthma therapy as recommended by current guidelines. (P/PT) |
|
Understand the literature that lead to the change in guidelines to use SMART therapy first line. (P) |
|
Recognize the limitations of older antiepileptic drugs. (P/PT) |
|
Discuss some of the lesser used newer epileptic agents. (P/PT) |
|
List some considerations related to stopping antiepileptic drug therapy. (P) |
|
Compare current pharmacological interventions for obesity management in adult and pediatric patients. (P) |
|
Understand the benefits in patient outcomes from CGM use as explained by current clinical literature and guidelines, and identify patients for whom it is appropriate. (P) |
|
Identify insurance coverage requirements and prescribing essentials for all types of CGMs and patients. (P/PT) |
|
Compare common pharmacologic antidepressant agents based on their unique drug characteristics. (P) |
|
Determine potential place in therapy for new drugs for these indications. (P/PT) |
|
Identify the difference in inhaler types and be able to counsel patients on proper use. (P/PT) |
|
Review epilepsy impact and classification. (P/PT) |
|
Outline potential benefits and important adverse effects of some newer antiepileptic drugs. (P) |
|
Review the pharmacoeconomic concerns related to newer epileptic agents. (P/PT) |
|
Review guideline recommendations for the management of obesity. (P) |
|
Explain insurance coverage, costs, and access for medications for obesity management. (P/PT) |
Early Registration Fee - Pharmacists - In-person
$129.00Early Registration Fee - Pharmacists -Live Webinar
$109.00Early Registration Fee - Pharmacy Technician - In-person
$79.00Early Registration Fee - Pharmacy Technician -Live Webinar
$59.00Registration Fee - Pharmacists -In-person
$144.00Registration Fee - Pharmacists - Live Webinar
$124.00Registration Fee - Pharmacy Technician - In-person
$94.00Registration Fee - Pharmacy Technician -Live Webinar
$74.00Pharmacists and Pharmacy Technicians in all aspects of Pharmacy
MAHEC has a pay-up-front policy for all CE programs. The only exceptions will be for pre-approved programs where an individual payment plan is appropriate. Registrations received without accompanying payment will not be processed and participants who have not paid the course fee will not be admitted into the program.
Unless otherwise noted in course materials, the following cancellation policy applies to all programs: